Connection

Frank Alexis to Drug Carriers

This is a "connection" page, showing publications Frank Alexis has written about Drug Carriers.
Connection Strength

1.074
  1. Theranostic nanotechnologies: moving beyond imaging drug localization? Ther Deliv. 2014 Feb; 5(2):97-100.
    View in: PubMed
    Score: 0.441
  2. Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma. Pharm Res. 2021 Feb; 38(2):335-346.
    View in: PubMed
    Score: 0.180
  3. Polymeric nanoparticle technologies for oral drug delivery. Clin Gastroenterol Hepatol. 2014 Oct; 12(10):1605-10.
    View in: PubMed
    Score: 0.113
  4. Nanotechnologies for noninvasive measurement of drug release. Mol Pharm. 2014 Jan 06; 11(1):24-39.
    View in: PubMed
    Score: 0.109
  5. Nanoparticle technologies for cancer therapy. Handb Exp Pharmacol. 2010; (197):55-86.
    View in: PubMed
    Score: 0.083
  6. Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2008 Aug; 2(8):1696-702.
    View in: PubMed
    Score: 0.075
  7. Radioactive polymeric nanoparticles for biomedical application. Drug Deliv. 2020 Dec; 27(1):1544-1561.
    View in: PubMed
    Score: 0.044
  8. Multifunctional yolk-in-shell nanoparticles for pH-triggered drug release and imaging. Small. 2014 Aug 27; 10(16):3364-70.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.